Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Summary

The purpose of this study is to assess the safety and efficacy of azelaic acid (AzA) foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea compared to its vehicle.

Timeline

Start

2012-09

Primary completion

2014-01

Completion

2014-01

Publications

• Results Draelos ZD, Elewski BE, Harper JC, Sand M, Staedtler G, Nkulikiyinka R, Shakery K. A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea. Cutis. 2015 Jul;96(1):54-61.

Drugs

Indications